These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11406841)

  • 41. A note on P-values under group sequential testing and nonproportional hazards.
    Gillen DL; Emerson SS
    Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multilevel mixture cure models with random effects.
    Lai X; Yau KK
    Biom J; 2009 Jun; 51(3):456-66. PubMed ID: 19588451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.
    Katsahian S; Resche-Rigon M; Chevret S; Porcher R
    Stat Med; 2006 Dec; 25(24):4267-78. PubMed ID: 16960919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Semiparametric analysis of survival data with left truncation and dependent right censoring.
    Jiang H; Fine JP; Chappell R
    Biometrics; 2005 Jun; 61(2):567-75. PubMed ID: 16011706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interval estimation of the mean response in a log-regression model.
    Wu J; Wong AC; Wei W
    Stat Med; 2006 Jun; 25(12):2125-35. PubMed ID: 16220472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On tests of rate ratio under standard inverse sampling.
    Tang ML; Liao YJ; Ng HK
    Comput Methods Programs Biomed; 2008 Mar; 89(3):261-8. PubMed ID: 18164512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A nonparametric method for penetrance function estimation.
    Alarcon F; Bonaïti-Pellié C; Harari-Kermadec H
    Genet Epidemiol; 2009 Jan; 33(1):38-44. PubMed ID: 18618769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new estimation method for the semiparametric accelerated failure time mixture cure model.
    Zhang J; Peng Y
    Stat Med; 2007 Jul; 26(16):3157-71. PubMed ID: 17094075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome.
    Cheng J
    Biometrics; 2009 Mar; 65(1):96-103. PubMed ID: 18373714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
    Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
    Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A likelihood ratio statistic for testing goodness of fit with randomly censored data.
    Turnbull BW; Weiss L
    Biometrics; 1978 Sep; 34(3):367-75. PubMed ID: 719120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative.
    Anisimova M; Gascuel O
    Syst Biol; 2006 Aug; 55(4):539-52. PubMed ID: 16785212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-inferiority trial design for recurrent events.
    Cook RJ; Lee KA; Li H
    Stat Med; 2007 Nov; 26(25):4563-77. PubMed ID: 17380542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limited-information goodness-of-fit testing of item response theory models for sparse 2 tables.
    Cai L; Maydeu-Olivares A; Coffman DL; Thissen D
    Br J Math Stat Psychol; 2006 May; 59(Pt 1):173-94. PubMed ID: 16709285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testing for crossover of two hazard functions using Gail and Simon's method.
    Chen YH; Liu GH
    J Biopharm Stat; 2006 May; 16(3):313-26. PubMed ID: 16724487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Weighted nonparametric maximum likelihood estimate of a mixing distribution in nonrandomized clinical trials.
    Liu C; Xie J; Zhang Y
    Stat Med; 2007 Dec; 26(29):5303-19. PubMed ID: 17497612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analyzing survival curves at a fixed point in time.
    Klein JP; Logan B; Harhoff M; Andersen PK
    Stat Med; 2007 Oct; 26(24):4505-19. PubMed ID: 17348080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On robustness of marginal regression coefficient estimates and hazard functions in multivariate survival analysis of family data when the frailty distribution is mis-specified.
    Hsu L; Gorfine M; Malone K
    Stat Med; 2007 Nov; 26(25):4657-78. PubMed ID: 17348081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parameters of a dose-response model are on the boundary: what happens with BMDL?
    Kopylev L; Fox J
    Risk Anal; 2009 Jan; 29(1):18-25. PubMed ID: 18808395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.